-transparent.png){kind=logo}
Pseudo-alpha- and pseudo-beta-DL-glucose, the isomers of 5-hydroxymethyl-1,2,3,4-cyclohexanetetrol with alpha-gluco and beta-gluco configurations, were used as synthetic analogs of glucose anomers to study the mechanism of glucose-stimulated insulin release by pancreatic islets. Neither isomer was phosphorylated by liver glucokinase nor stimulated insulin release from islets. Incubation of islets with pseudo-alpha-DL-glucose resulted in a considerable accumulation of the glucose analog, probably the D form, in islets. The alpha-isomer, but not the beta-isomer, inhibited both glucose-stimulated insulin release (44% inhibition at 20 mM) and islet glucokinase activity (36% inhibition at 20 mM) in a concentration-dependent manner and to a comparable degree. These results strongly suggest that the inhibition of glucose-stimulated insulin release by pseudo-alpha-DL-glucose is due to the inhibition of islet glucokinase by the glucose analog, providing additional evidence for the essential role of islet glucokinase in glucose-stimulated insulin release.
I Miwa, and
H Hara, and
J Okuda, and
T Suami, and
S Ogawa
July 1982,
The American journal of physiology,
I Miwa, and
H Hara, and
J Okuda, and
T Suami, and
S Ogawa
March 1979,
Clinical pharmacology and therapeutics,
I Miwa, and
H Hara, and
J Okuda, and
T Suami, and
S Ogawa
February 1994,
Japanese journal of pharmacology,
I Miwa, and
H Hara, and
J Okuda, and
T Suami, and
S Ogawa
July 1992,
Diabetes,
I Miwa, and
H Hara, and
J Okuda, and
T Suami, and
S Ogawa
May 1991,
The Journal of biological chemistry,
I Miwa, and
H Hara, and
J Okuda, and
T Suami, and
S Ogawa
April 1995,
Endocrine,
I Miwa, and
H Hara, and
J Okuda, and
T Suami, and
S Ogawa
July 1993,
Diabetes,
I Miwa, and
H Hara, and
J Okuda, and
T Suami, and
S Ogawa
June 1985,
Endocrinology,
I Miwa, and
H Hara, and
J Okuda, and
T Suami, and
S Ogawa
February 1996,
Bioscience reports,
I Miwa, and
H Hara, and
J Okuda, and
T Suami, and
S Ogawa
November 1981,
Diabetes,
